Zydus Cadila May Seek Emergency Use Nod For Vaccine Next Week: Report
#Coronavirus | 'cadila'>Zydus Cadila@ZydusUniverse ) final analysis of vaccine is underway, it appears that vaccine results should be ready by July,' says Dr NK Arora, head of the National Vax Advisory Group in conversation with @ShereenBhan .
Visited the Zydus Biotech Park in Ahmedabad to know more about the indigenous DNA based vaccine being developed by cadila'>Zydus Cadila. I compliment the team behind this effort for their work. Government of India is actively working with them to support them in this journey.
3 vaccines at clinical trial stage in India. Cadila and Bharat Biotech have completed phase-I trials. Serum Institute has completed phase II-B3 trials, and will start phase-III trial (with 1500 patients at 14 locations) after clearances: Prof (Dr.) Balram Bhargava, DG, ICMR
OnCNBCTV18 | @sushilkedia , founder, @kedianomics tells @_anujsinghal & @SurabhiUpadhyay that he sees #Nifty range at 9,450-9,050 & that he is positive on Cadila & Aurobindo Pharma#TrackingTheTechnicals
Pharmaceutical industry has significantly increased the production of hydroxychloroquine (HCQ). 20 crore tablets of HCQ have been produced by the industry this month: Pankaj Patel, CEO of cadila'>Zydus Cadila, in Ahmedabad#COVID19